CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | C4-dicarboxylic acid |
|
Accession: | CHEBI:66873
|
browse the term
|
Definition: | Any dicarboxylic acid that contains four carbon atoms. |
Synonyms: | related_synonym: | C4-dicarboxylic acids |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:61336 |
|
|
|
G |
Folh1 |
folate hydrolase 1 |
affects binding multiple interactions |
ISO |
isospaglumic acid binds to FOLH1 protein [2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] |
CTD |
PMID:24508213 |
|
NCBI chr 1:150,323,768...150,395,415
Ensembl chr 1:150,323,768...150,395,415
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of ACTA2 mRNA] Artesunate results in decreased expression of ACTA2 mRNA; Artesunate results in decreased expression of ACTA2 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization |
ISO |
artesunate affects the localization of AIFM1 protein |
CTD |
PMID:24704559 |
|
NCBI chr X:135,304,063...135,343,062
Ensembl chr X:135,304,066...135,343,087
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
Artesunate results in increased expression of ATG12 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr18:40,721,799...40,732,143
Ensembl chr18:40,721,800...40,732,126
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
Artesunate results in increased expression of ATG3 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr11:60,585,192...60,613,706
Ensembl chr11:60,585,171...60,613,718
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Artesunate results in increased expression of ATG5 mRNA |
CTD |
PMID:30551460 |
|
NCBI chr20:49,301,783...49,393,147
Ensembl chr20:49,318,308...49,393,140
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
artesunate results in increased expression of BAX protein [1,2-Dimethylhydrazine co-treated with artesunate] results in increased expression of BAX protein |
CTD |
PMID:24704559 PMID:29031619 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
artesunate results in decreased expression of BCL2 protein [1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein |
CTD |
PMID:24704559 PMID:29031619 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
increases response to substance |
ISO |
BST1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr14:71,798,218...71,814,540
Ensembl chr14:71,798,651...71,814,523
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
artesunate results in increased activity of CASP3 protein |
CTD |
PMID:19513562 PMID:24704559 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
affects expression |
ISO |
artesunate affects the expression of CASP9 protein |
CTD |
PMID:24704559 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
increases expression decreases response to substance |
ISO |
artesunate results in increased expression of CAT protein CAT protein results in decreased susceptibility to artesunate |
CTD |
PMID:19513562 PMID:20144594 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cct2 |
chaperonin containing TCP1 subunit 2 |
decreases response to substance |
ISO |
CCT2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:60,106,532...60,122,779
Ensembl chr 7:60,109,974...60,122,805
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK1 protein] |
CTD |
PMID:31664825 |
|
NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions increases phosphorylation |
ISO |
APOBEC3C protein promotes the reaction [Artesunate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:31664825 |
|
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
|
|
G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
increases response to substance |
ISO |
CLIP4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 6:23,222,020...23,316,962
Ensembl chr 6:23,222,021...23,316,962
|
|
G |
Coq8a |
coenzyme Q8A |
decreases response to substance |
ISO |
COQ8A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr13:98,451,629...98,480,438
Ensembl chr13:98,451,637...98,480,419
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CTNNB1 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Dbh |
dopamine beta-hydroxylase |
increases response to substance |
ISO |
DBH mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:5,709,236...5,731,895
Ensembl chr 3:5,709,236...5,731,898
|
|
G |
Des |
desmin |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of DES mRNA] Artesunate results in decreased expression of DES mRNA; Artesunate results in decreased expression of DES protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:82,556,574...82,564,288
Ensembl chr 9:82,556,573...82,564,294
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
artesunate binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
artesunate results in increased expression of FAS protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Flna |
filamin A |
increases response to substance |
ISO |
FLNA mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr X:156,460,785...156,487,245
Ensembl chr X:156,463,953...156,487,245
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions decreases expression |
ISO |
Deferoxamine inhibits the reaction [Artesunate results in decreased expression of FN1 mRNA] Artesunate results in decreased expression of FN1 mRNA; Artesunate results in decreased expression of FN1 protein |
CTD |
PMID:30551460 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fth1 |
ferritin heavy chain 1 |
decreases expression multiple interactions |
ISO |
Artesunate results in decreased expression of FTH1 mRNA; Artesunate results in decreased expression of FTH1 protein Chloroquine inhibits the reaction [Artesunate results in decreased expression of FTH1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
Fzd7 |
frizzled class receptor 7 |
increases response to substance |
ISO |
FZD7 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 9:66,305,731...66,308,550
Ensembl chr 9:66,305,731...66,308,550
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects response to substance decreases response to substance |
ISO |
GCLC mRNA affects the susceptibility to artesunate GCLC mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases response to substance |
ISO |
GCLM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases activity multiple interactions |
ISO |
Artesunate results in decreased activity of GPX4 protein Artesunate inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX4 protein] |
CTD |
PMID:30551460 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
affects response to substance |
ISO |
GSTM4 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 2:210,834,013...210,839,242
Ensembl chr 2:210,833,884...210,839,295
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
artesunate results in decreased expression of GSTP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt2 |
glutathione S-transferase, theta 2 |
affects response to substance |
ISO |
GSTT2 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr20:13,760,810...13,764,481
Ensembl chr20:13,760,810...13,764,475
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
affects response to substance |
ISO |
GSTZ1 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr 6:111,176,798...111,187,246
Ensembl chr 6:111,176,798...111,187,244
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL1B protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL1B mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL1B protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Artesunate inhibits the reaction [Ethanol results in increased expression of IL6 protein]; Artesunate inhibits the reaction [Glucose results in increased expression of IL6 mRNA]; Artesunate inhibits the reaction [Glucose results in increased secretion of IL6 protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases response to substance |
ISO |
ITGB1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr19:61,677,512...61,725,537
Ensembl chr19:61,677,542...61,725,535
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
affects response to substance |
ISO |
MGST3 mRNA affects the susceptibility to artesunate |
CTD |
PMID:15796179 |
|
NCBI chr13:85,601,499...85,622,392
Ensembl chr13:85,601,499...85,622,314
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein] |
CTD |
PMID:29031619 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MMP9 protein] Chloroquine inhibits the reaction [Artesunate results in decreased expression of MMP9 mRNA] |
CTD |
PMID:29031619 PMID:30551460 |
|
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased activity of MPO protein] |
CTD |
PMID:27474069 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases response to substance |
ISO |
MTHFD2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 4:115,004,433...115,015,965
Ensembl chr 4:115,004,448...115,015,965
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of MYD88 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
|
|
G |
Naca |
nascent polypeptide associated complex subunit alpha |
decreases response to substance |
ISO |
NACA mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:2,458,283...2,470,674
Ensembl chr 7:2,458,264...2,470,674
|
|
G |
Nckap1 |
NCK-associated protein 1 |
increases response to substance |
ISO |
NCKAP1 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 3:67,725,180...67,804,680
Ensembl chr 3:67,725,947...67,787,990
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of NCOA4 mRNA] Artesunate results in decreased expression of NCOA4 mRNA; Artesunate results in decreased expression of NCOA4 protein |
CTD |
PMID:30551460 |
|
NCBI chr16:8,302,950...8,323,294
Ensembl chr16:8,302,950...8,323,293
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
affects localization |
ISO |
artesunate affects the localization of NFE2L2 protein |
CTD |
PMID:26340163 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of NLRP3 protein] |
CTD |
PMID:30031708 |
|
NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
artesunate results in increased cleavage of PARP1 protein |
CTD |
PMID:24704559 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
artesunate binds to and results in increased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 mRNA; [Carbon Tetrachloride results in increased susceptibility to Artesunate] which results in increased expression of PTGS2 protein |
CTD |
PMID:30551460 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of RELA protein]; artesunate inhibits the reaction [Glucose results in increased phosphorylation of RELA protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rpa2 |
replication protein A2 |
increases phosphorylation |
ISO |
Artesunate results in increased phosphorylation of RPA2 protein |
CTD |
PMID:31664825 |
|
NCBI chr 5:150,957,041...150,967,597
Ensembl chr 5:150,957,001...150,968,269
|
|
G |
Rpl41 |
ribosomal protein L41 |
decreases response to substance |
ISO |
RPL41 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 7:2,972,897...2,973,977
Ensembl chr 7:2,972,900...2,973,977
|
|
G |
Rpl6 |
ribosomal protein L6 |
decreases response to substance |
ISO |
RPL6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr12:40,877,578...40,882,032
Ensembl chr12:40,877,613...40,881,124
|
|
G |
Rpl7 |
ribosomal protein L7 |
decreases response to substance |
ISO |
RPL7 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:2,633,517...2,636,525
Ensembl chr 5:2,632,712...2,640,021
|
|
G |
Rps12 |
ribosomal protein S12 |
decreases response to substance |
ISO |
RPS12 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:22,758,214...22,760,370
Ensembl chr 1:22,758,212...22,760,370
|
|
G |
Rps15a |
ribosomal protein S15a |
decreases response to substance |
ISO |
RPS15A mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:187,759,865...187,766,734
Ensembl chr 1:187,759,480...187,766,709
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases response to substance |
ISO |
RPS6 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
|
|
G |
Slc25a19 |
solute carrier family 25 member 19 |
decreases response to substance |
ISO |
SLC25A19 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:104,166,594...104,179,523
Ensembl chr10:104,166,598...104,179,523
|
|
G |
Sp1 |
Sp1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of SP1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions decreases expression |
ISO |
Chloroquine inhibits the reaction [Artesunate results in decreased expression of SQSTM1 protein] Artesunate results in decreased expression of SQSTM1 mRNA; Artesunate results in decreased expression of SQSTM1 protein |
CTD |
PMID:30551460 |
|
NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
decreases response to substance |
ISO |
SRSF2 mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression multiple interactions |
ISO |
Artesunate results in increased expression of TIMP1 mRNA Chloroquine inhibits the reaction [Artesunate results in increased expression of TIMP1 mRNA] |
CTD |
PMID:30551460 |
|
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
artesunate inhibits the reaction [Glucose results in increased expression of TLR4 protein] |
CTD |
PMID:30031708 |
|
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
artesunate inhibits the reaction [Ethanol results in increased expression of TNF protein]; artesunate inhibits the reaction [Glucose results in increased expression of TNF mRNA]; artesunate inhibits the reaction [Glucose results in increased secretion of TNF protein] |
CTD |
PMID:27474069 PMID:30031708 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects response to substance |
ISO |
TPT1 protein affects the susceptibility to artesunate |
CTD |
PMID:15878303 |
|
NCBI chr15:57,891,680...57,894,504
Ensembl chr15:57,891,680...57,894,504
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
decreases response to substance |
ISO |
TUFM mRNA results in decreased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr 1:197,903,582...197,907,189
Ensembl chr 1:197,903,582...197,907,189
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of VEGFA protein] |
CTD |
PMID:29031619 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Yy1 |
YY1 transcription factor |
decreases expression |
ISO |
artesunate results in decreased expression of YY1 protein |
CTD |
PMID:19513562 |
|
NCBI chr 6:132,702,443...132,726,848
Ensembl chr 6:132,702,448...132,727,046
|
|
G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
increases response to substance |
ISO |
ZBTB4 mRNA results in increased susceptibility to artesunate |
CTD |
PMID:20144594 |
|
NCBI chr10:56,367,586...56,388,296
Ensembl chr10:56,381,813...56,385,960
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCA1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ABCD1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:157,073,860...157,095,652
Ensembl chr X:157,072,736...157,095,274
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:132,294,564...132,343,169
Ensembl chr 7:132,294,562...132,343,169
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACAA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:128,027,880...128,036,471
Ensembl chr 8:128,027,958...128,036,236
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:127,836,235...127,845,296
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACACB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:48,127,149...48,238,969
Ensembl chr12:48,127,149...48,238,887
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADS mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADS mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:47,254,503...47,263,747
Ensembl chr12:47,254,484...47,263,747
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:56,619,321...56,624,468
Ensembl chr10:56,619,303...56,624,526
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO EXP |
Aspartame metabolite results in decreased activity of ACHE protein |
CTD |
PMID:16129618 PMID:17580119 PMID:17673349 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:56,425,076...56,481,218
Ensembl chr 5:56,425,024...56,481,218
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACOT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:107,485,088...107,493,082
Ensembl chr 6:107,485,249...107,493,798
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ADGRE1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
Aspartame results in decreased expression of AGT mRNA |
CTD |
PMID:31655124 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
Aspartame results in decreased expression of AGTR1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr17:35,907,102...35,958,136
Ensembl chr17:35,907,108...35,958,077
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ALOX15 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
|
|
G |
Apoe |
apolipoprotein E |
decreases expression |
ISO |
Aspartame results in decreased expression of APOE mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
[Aspartame co-treated with Methotrexate] results in increased expression of BAX mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of BAX protein [Fats, Unsaturated co-treated with Aspartame] affects the expression of BAX mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of BAX mRNA |
CTD |
PMID:23783067 PMID:25009784 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA; [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein |
CTD |
PMID:25009784 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Cabp2 |
calcium binding protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CABP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CABP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:219,329,186...219,335,046
Ensembl chr 1:219,329,574...219,335,043
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:25,453,236...25,749,550
Ensembl chr19:25,526,751...25,749,550
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA1I mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1I mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283
|
|
G |
Cacna2d4 |
calcium voltage-gated channel auxiliary subunit alpha2delta 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNA2D4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA2D4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:151,298,548...151,409,263
Ensembl chr 4:151,298,548...151,409,263
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:81,673,862...82,019,219
Ensembl chr17:81,798,756...82,017,682
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:95,954,160...96,015,484
Ensembl chr10:95,951,234...96,015,499
|
|
G |
Cacng8 |
calcium voltage-gated channel auxiliary subunit gamma 8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CACNG8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:64,330,106...64,350,338
Ensembl chr 1:64,330,106...64,350,338
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALHM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALHM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:266,908,367...266,914,093
Ensembl chr 1:266,908,369...266,914,093
|
|
G |
Calr3 |
calreticulin 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CALR3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALR3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:19,097,391...19,124,062
Ensembl chr16:19,097,391...19,124,062
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CANT1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CANT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:107,432,500...107,445,634
Ensembl chr10:107,432,506...107,445,522
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
[Aspartame co-treated with Methotrexate] results in increased expression of CASP3 mRNA; [Aspartame co-treated with Methotrexate] results in increased expression of CASP3 protein modified form |
CTD |
PMID:25009784 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CASP9 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CASP9 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Aspartame co-treated with Methotrexate] results in increased activity of CAT protein |
CTD |
PMID:25009784 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of CCL2 protein; [Sodium Glutamate co-treated with Aspartame] inhibits the reaction [Fats, Unsaturated results in increased expression of CCL2 protein] |
CTD |
PMID:23783067 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cherp |
calcium homeostasis endoplasmic reticulum protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:19,068,783...19,081,837
Ensembl chr16:19,068,783...19,081,837
|
|
G |
Cmc1 |
C-x(9)-C motif containing 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:126,437,345...126,495,347
Ensembl chr 8:126,437,345...126,495,347
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:78,168,691...78,173,845 NCBI chr10:78,102,620...78,174,584
Ensembl chr10:78,111,050...78,174,584
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of COX7A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX7A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:88,619,619...88,650,672
Ensembl chr 1:91,071,493...91,074,294 Ensembl chr 1:91,071,493...91,074,294
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of CPT1B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:130,395,211...130,404,731
Ensembl chr 7:130,395,194...130,405,347
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:100,955,094...100,970,579
Ensembl chr 1:100,955,095...100,969,560
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CREB1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CSF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity |
EXP |
Aspartame results in increased activity of CYP1A1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity |
EXP |
Aspartame results in increased activity of CYP1A2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions |
EXP |
Aspartame results in increased expression of and results in increased activity of CYP2B1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases activity |
EXP |
Aspartame results in increased activity of CYP2B2 protein |
CTD |
PMID:16937917 |
|
NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
Aspartame results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:16937917 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases activity |
EXP |
Aspartame results in increased activity of CYP3A62 protein |
CTD |
PMID:16937917 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DIABLO mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DIABLO mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
|
|
G |
Dnajc27 |
DnaJ heat shock protein family (Hsp40) member C27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of DNAJC27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DNAJC27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:28,515,054...28,544,756
Ensembl chr 6:28,515,025...28,544,790
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of E2F1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of E2F1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
Edn2 |
endothelin 2 |
decreases expression |
ISO |
Aspartame results in decreased expression of EDN2 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 5:139,098,472...139,106,396
Ensembl chr 5:139,100,898...139,105,792
|
|
G |
Ednra |
endothelin receptor type A |
decreases expression |
ISO |
Aspartame results in decreased expression of EDNRA mRNA |
CTD |
PMID:31655124 |
|
NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EHHADH mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EHHADH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of EPHX2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EPHX2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:42,757,241...42,794,211
Ensembl chr15:42,757,235...42,794,279
|
|
G |
F2 |
coagulation factor II |
decreases activity |
ISO |
Aspartame analog results in decreased activity of F2 protein; Aspartame results in decreased activity of F2 protein |
CTD |
PMID:15572260 |
|
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
increases expression |
ISO |
Aspartame results in increased expression of FGF1 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of FOXO3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GADD45B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
|
|
G |
Gfm2 |
GTP dependent ribosome recycling factor mitochondrial 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of GFM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GFM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:27,949,195...27,984,045
Ensembl chr 2:27,949,208...27,984,256
|
|
G |
Gip |
gastric inhibitory polypeptide |
multiple interactions |
ISO |
Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]; Sodium Glutamate inhibits the reaction [Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]] |
CTD |
PMID:23783067 |
|
NCBI chr10:83,835,080...83,848,399
Ensembl chr10:83,840,303...83,848,396
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
[Aspartame co-treated with Methotrexate] results in decreased activity of GSR protein |
CTD |
PMID:25009784 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:27,589,840...27,628,921
Ensembl chr 6:27,589,657...27,629,175
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of HADHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:27,555,408...27,589,539
Ensembl chr 6:27,555,412...27,582,995
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:147,716,664...147,743,723
Ensembl chr 5:147,716,664...147,743,723
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:90,140,183...90,169,853
Ensembl chr10:90,140,183...90,151,042
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HGF mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
ISO |
Aspartame results in increased expression of HRAS |
CTD |
PMID:17354619 |
|
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
|
|
G |
Hspg2 |
heparan sulfate proteoglycan 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:155,812,096...155,913,751
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
|
|
G |
Il11 |
interleukin 11 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL11 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:72,636,959...72,643,255
Ensembl chr 1:72,635,267...72,643,255
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Aspartame results in increased expression of IL1B mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il3 |
interleukin 3 |
decreases expression |
ISO |
Aspartame results in decreased expression of IL3 mRNA |
CTD |
PMID:31655124 |
|
NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
Aspartame results in increased secretion of IL6 protein |
CTD |
PMID:20837131 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Immt |
inner membrane mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of IMMT mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IMMT mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:99,753,446...99,789,921
Ensembl chr 4:99,753,500...99,792,484
|
|
G |
Ins2 |
insulin 2 |
increases expression multiple interactions |
ISO |
Aspartame results in increased expression of INS protein [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] results in increased expression of INS2 protein; Aspartame inhibits the reaction [Fats, Unsaturated results in increased expression of INS2 protein] |
CTD |
PMID:1805284 PMID:23783067 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Kdr |
kinase insert domain receptor |
increases secretion |
ISO |
Aspartame results in increased secretion of KDR protein |
CTD |
PMID:20837131 |
|
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
|
|
G |
Lep |
leptin |
decreases expression multiple interactions |
EXP ISO |
Aspartame results in decreased expression of LEP protein [Fats, Unsaturated co-treated with Aspartame] results in increased expression of LEP protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein] |
CTD |
PMID:11890951 PMID:23783067 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lipg |
lipase G, endothelial type |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LIPG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:70,903,528...70,924,434
Ensembl chr18:70,901,710...70,924,708
|
|
G |
LOC100912008 |
uncharacterized LOC100912008 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:4,869,790...4,872,633
Ensembl chr 3:4,869,795...4,872,632
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:70,846,313...70,927,028
Ensembl chr 7:70,846,344...70,926,903
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:55,665,153...55,822,484
Ensembl chr 3:55,665,145...55,822,551
|
|
G |
Lrp4 |
LDL receptor related protein 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:80,362,643...80,416,684
Ensembl chr 3:80,362,858...80,416,679
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20837131 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
Aspartame results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20837131 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mcu |
mitochondrial calcium uniporter |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MCU mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MCU mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:29,037,452...29,199,224
Ensembl chr20:29,038,480...29,199,224
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MED23 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:21,539,765...21,587,675
Ensembl chr 1:21,539,765...21,586,910
|
|
G |
Mef2d |
myocyte enhancer factor 2D |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MEF2D mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:187,511,775...187,541,285
Ensembl chr 2:187,512,164...187,538,026
|
|
G |
Micos10 |
mitochondrial contact site and cristae organizing system subunit 10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MINOS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MINOS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:157,546,855...157,573,183
Ensembl chr 5:157,546,856...157,573,183
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MICU1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MICU1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:29,284,833...29,433,617
Ensembl chr20:29,284,853...29,432,258
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL20 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL20 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:173,248,245...173,252,775
Ensembl chr 5:173,248,245...173,252,775
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:113,603,533...113,626,893
Ensembl chr 8:113,603,533...113,626,893
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:86,920,679...86,923,626
Ensembl chr 1:86,920,680...86,923,575
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:85,947,763...85,951,891
Ensembl chr14:85,947,765...85,951,899
|
|
G |
Mrps27 |
mitochondrial ribosomal protein S27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:29,598,344...29,666,711
Ensembl chr 2:29,598,344...29,666,724
|
|
G |
Mrps7 |
mitochondrial ribosomal protein S7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:104,155,805...104,158,840
Ensembl chr10:104,155,805...104,158,839
|
|
G |
Mtfp1 |
mitochondrial fission process 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of MTFP1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MTFP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:84,330,223...84,334,063
Ensembl chr14:84,330,218...84,334,066
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Aspartame results in increased expression of MYC |
CTD |
PMID:17354619 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NCOR1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
|
|
G |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:35,125,516...35,163,182
Ensembl chr 7:35,125,424...35,167,406
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFA5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:51,590,413...51,598,771
Ensembl chr 4:51,590,413...51,598,771
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB10 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB10 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:14,090,128...14,092,289
Ensembl chr10:14,090,128...14,092,289
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:67,378,188...67,385,267
Ensembl chr 4:67,378,188...67,385,266
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFB6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:56,567,109...56,576,676
Ensembl chr 5:56,567,109...56,576,676
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:69,919,863...69,953,182
Ensembl chr 9:69,919,867...69,953,182
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFS6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:26,471,173...26,471,587
Ensembl chr 2:26,471,173...26,471,584
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of NDUFV1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFV1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:219,254,293...219,259,328
Ensembl chr 1:219,254,279...219,259,448
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOTCH1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:3,905,562...3,951,015
Ensembl chr 3:3,905,453...3,951,025
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:104,909,328...104,932,508
Ensembl chr X:104,909,326...104,932,508
|
|
G |
Nppb |
natriuretic peptide B |
decreases expression |
ISO |
Aspartame results in decreased expression of NPPB mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
EXP |
Aspartame results in decreased expression of NPY protein |
CTD |
PMID:11890951 |
|
NCBI chr 4:79,557,856...79,565,059
Ensembl chr 4:79,557,854...79,565,097
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NR1I3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
|
|
G |
Onecut1 |
one cut homeobox 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ONECUT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:81,765,779...81,799,894
Ensembl chr 8:81,766,041...81,793,577
|
|
G |
Pdha2 |
pyruvate dehydrogenase E1 subunit alpha 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHA2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHA2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:246,736,449...246,737,997
Ensembl chr 2:246,736,459...246,737,997
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:18,540,826...18,546,855
Ensembl chr15:18,539,210...18,546,854
|
|
G |
Pex1 |
peroxisomal biogenesis factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:27,659,376...27,698,037
Ensembl chr 4:27,659,381...27,698,037
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX11A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX11A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:141,474,189...141,481,270
Ensembl chr 1:141,474,180...141,481,315
|
|
G |
Pex13 |
peroxisomal biogenesis factor 13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:108,394,299...108,411,994
Ensembl chr14:108,394,303...108,412,823
|
|
G |
Pex5 |
peroxisomal biogenesis factor 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:156,983,914...157,009,675
Ensembl chr 4:156,983,915...157,009,674
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PEX7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:15,311,768...15,374,702
Ensembl chr 1:15,311,770...15,374,850
|
|
G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:47,413,453...47,440,682
Ensembl chr13:47,413,458...47,440,682
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PFKFB4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:117,733,347...117,776,525
Ensembl chr 8:117,737,117...117,775,386
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:57,161,921...57,181,148
Ensembl chr10:57,163,174...57,179,730
|
|
G |
Plg |
plasminogen |
decreases expression |
ISO |
Aspartame results in decreased expression of PLG mRNA |
CTD |
PMID:31655124 |
|
NCBI chr 1:48,521,828...48,563,895
Ensembl chr 1:48,521,772...48,563,776
|
|
G |
Plxnd1 |
plexin D1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLXND1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:147,854,309...147,894,170
Ensembl chr 4:147,854,309...147,893,992
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of POLG mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of POLG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:141,172,117...141,188,893
Ensembl chr 1:141,172,531...141,188,031
|
|
G |
Pomc |
proopiomelanocortin |
increases expression |
ISO |
Aspartame results in increased expression of POMC protein alternative form |
CTD |
PMID:1805284 |
|
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PPARGC1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARGC1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of PRDX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PRDX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:222,164,462...222,167,447
Ensembl chr 1:222,164,462...222,167,447
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ROCK1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:1,273,490...1,390,790
Ensembl chr18:1,273,453...1,390,190
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:189,906,022...189,912,516
Ensembl chr 2:189,906,022...189,912,516
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:159,484,378...159,505,063
Ensembl chr 5:159,484,370...159,505,064
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:86,948,866...86,971,954
Ensembl chr 1:86,948,918...86,971,952
|
|
G |
Slc15a1 |
solute carrier family 15 member 1 |
decreases activity |
ISO |
Aspartame results in decreased activity of SLC15A1 protein |
CTD |
PMID:15846457 |
|
NCBI chr15:106,800,081...106,844,668
Ensembl chr15:106,800,081...106,844,426
|
|
G |
Slc4a2 |
solute carrier family 4 member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC4A2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:7,264,677...7,282,355
Ensembl chr 4:7,264,683...7,281,223
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SLC8A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC8A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:4,244,076...4,564,262
Ensembl chr 6:4,258,991...4,520,604
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SREBF2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of STAT3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Surf1 |
SURF1, cytochrome c oxidase assembly factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:5,461,717...5,464,560
Ensembl chr 3:4,869,795...4,872,632
|
|
G |
Tas1r2 |
taste 1 receptor member 2 |
multiple interactions affects binding |
ISO |
Aspartame binds to and results in increased activity of TAS1R2 protein; lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein]; Aspartame binds to TAS1R2 protein |
CTD |
PMID:15353592 PMID:17168764 PMID:17935609 PMID:20173092 |
|
NCBI chr 5:158,119,894...158,135,733
Ensembl chr 5:158,042,587...158,135,733
|
|
G |
Tas1r3 |
taste 1 receptor member 3 |
affects binding multiple interactions |
ISO |
Aspartame binds to [TAS1R2 protein binds to TAS1R3 protein] lactisole inhibits the reaction [Aspartame results in increased activity of [TAS1R3 protein binds to TAS1R2 protein]] |
CTD |
PMID:17168764 PMID:17935609 |
|
NCBI chr 5:173,307,325...173,312,950
Ensembl chr 5:173,308,870...173,312,023
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TFAM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TFAM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of THBS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] results in increased expression of TNF protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of TNF protein] |
CTD |
PMID:23783067 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Aspartame results in increased expression of TRP53 [Fats, Unsaturated co-treated with Aspartame] affects the expression of TRP53 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TRP53 mRNA |
CTD |
PMID:17354619 PMID:23783067 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases activity |
ISO |
Aspartame results in increased activity of TRPV1 protein |
CTD |
PMID:17567713 PMID:18804451 |
|
NCBI chr10:59,799,123...59,824,208
Ensembl chr10:59,799,123...59,824,679
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:197,903,582...197,907,189
Ensembl chr 1:197,903,582...197,907,189
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UCP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UCP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Aspartame] affects the expression of UQCR11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UQCR11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:12,171,146...12,175,838
Ensembl chr 7:12,171,185...12,175,835
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases secretion |
ISO |
Aspartame results in increased secretion of VEGFA protein |
CTD |
PMID:20837131 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of XDH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
affects localization |
ISO |
citraconic acid affects the localization of BACH1 protein |
CTD |
PMID:27277809 |
|
NCBI chr11:27,364,913...27,398,713
Ensembl chr11:27,364,916...27,398,842
|
|
G |
Foxm1 |
forkhead box M1 |
increases expression |
ISO |
citraconic acid results in increased expression of FOXM1 protein |
CTD |
PMID:28289076 |
|
NCBI chr 4:161,685,236...161,697,633
Ensembl chr 4:161,685,258...161,696,305
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
citraconic acid results in increased expression of FTH1 protein |
CTD |
PMID:28289076 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
Ftl1 |
ferritin light chain 1 |
multiple interactions increases expression |
ISO |
citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] |
CTD |
PMID:28289076 |
|
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP ISO |
citraconic acid results in increased expression of GCLC protein citraconic acid results in increased expression of GCLC mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP ISO |
citraconic acid results in increased expression of GCLM protein citraconic acid results in increased expression of GCLM mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO EXP |
citraconic acid results in increased expression of GSR mRNA citraconic acid results in increased expression of GSR protein |
CTD |
PMID:27277809 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
multiple interactions |
ISO |
citraconic acid binds to and results in increased activity of HCAR2 protein |
CTD |
PMID:18722346 |
|
NCBI chr12:38,160,464...38,161,546
Ensembl chr12:38,160,464...38,161,546
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP ISO |
citraconic acid results in increased expression of HMOX1 mRNA; citraconic acid results in increased expression of HMOX1 protein |
CTD |
PMID:27277809 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of ND1 mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of ND5 mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mterf1 |
mitochondrial transcription termination factor 1 |
increases expression |
ISO |
citraconic acid results in increased expression of MTERF1A mRNA |
CTD |
PMID:27277809 |
|
NCBI chr 4:27,365,310...27,372,374
Ensembl chr 4:27,365,376...27,372,372
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
multiple interactions affects localization |
ISO |
NFE2L2 protein affects the reaction [citraconic acid results in increased expression of CYTB mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND1 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND5 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of ND6 mRNA]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] citraconic acid promotes the reaction [NFE2L2 protein results in increased expression of FTL protein]; NFE2L2 protein affects the reaction [citraconic acid results in increased expression of FTL protein] citraconic acid affects the localization of NFE2L2 protein |
CTD |
PMID:27277809 PMID:28289076 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
citraconic acid results in increased expression of NQO1 mRNA; citraconic acid results in increased expression of NQO1 protein |
CTD |
PMID:27277809 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Polrmt |
RNA polymerase mitochondrial |
increases expression multiple interactions |
ISO |
citraconic acid results in increased expression of POLRMT mRNA NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr 7:12,840,907...12,851,153
Ensembl chr 7:12,840,938...12,851,153
|
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of CASP3 protein |
CTD |
PMID:21105742 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of PARP1 protein |
CTD |
PMID:21105742 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases cleavage |
ISO |
diethyl fumarate results in increased cleavage of SPTAN1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 3:8,534,437...8,599,259
Ensembl chr 3:8,534,440...8,599,260
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
ISO |
diethyl malate affects the expression of ACTA2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actc1 |
actin, alpha, cardiac muscle 1 |
affects expression |
ISO |
diethyl malate affects the expression of ACTC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:105,507,403...105,512,939
Ensembl chr 3:105,507,403...105,512,939
|
|
G |
Actn3 |
actinin alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ACTN3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:220,120,532...220,136,460
Ensembl chr 1:220,120,533...220,136,470
|
|
G |
Adcy1 |
adenylate cyclase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ADCY1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:87,311,970...87,429,880
Ensembl chr14:87,312,203...87,421,659
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
affects expression |
ISO |
diethyl malate affects the expression of ADH1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857
|
|
G |
Agt |
angiotensinogen |
affects expression |
ISO |
diethyl malate affects the expression of AGT mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
C3 |
complement C3 |
affects expression |
ISO |
diethyl malate affects the expression of C3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr17:81,673,862...82,019,219
Ensembl chr17:81,798,756...82,017,682
|
|
G |
Cacnb4 |
calcium voltage-gated channel auxiliary subunit beta 4 |
affects expression |
ISO |
diethyl malate affects the expression of CACNB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:37,950,846...38,211,478
Ensembl chr 3:37,955,069...38,090,526
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CAMK2A mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr18:56,193,978...56,295,869
Ensembl chr18:56,193,978...56,295,869
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
affects expression |
ISO |
diethyl malate affects the expression of CCL20 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:88,918,359...88,921,017
Ensembl chr 9:88,918,433...88,921,001
|
|
G |
Ccl6 |
C-C motif chemokine ligand 6 |
affects expression |
ISO |
diethyl malate affects the expression of CCL6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
affects expression |
ISO |
diethyl malate affects the expression of CCL7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL11A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:216,863,423...217,056,523
Ensembl chr 2:216,863,428...217,056,523
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL2A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:139,454,945...139,484,403
Ensembl chr 7:139,455,242...139,483,997
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL3A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
affects expression |
ISO |
diethyl malate affects the expression of COL6A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561
|
|
G |
Comp |
cartilage oligomeric matrix protein |
affects expression |
ISO |
diethyl malate affects the expression of COMP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:20,798,437...20,807,070
Ensembl chr16:20,798,437...20,807,070
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of CXCL12 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of CXCL12 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
affects expression |
ISO |
diethyl malate affects the expression of CXCL1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
affects expression |
ISO |
diethyl malate affects the expression of CXCL5 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
affects expression |
ISO |
diethyl malate affects the expression of CYP2J9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
affects expression |
ISO |
diethyl malate affects the expression of DAPK2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:71,822,107...71,941,941
Ensembl chr 8:71,822,129...71,941,910
|
|
G |
Ddx58 |
DEXD/H-box helicase 58 |
affects expression |
ISO |
diethyl malate affects the expression of DDX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:56,486,584...56,536,898
Ensembl chr 5:56,500,734...56,536,772
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
affects expression |
ISO |
diethyl malate affects the expression of DHRS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
affects expression |
ISO |
diethyl malate affects the expression of DHX58 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:88,599,722...88,611,562
Ensembl chr10:88,599,680...88,611,105
|
|
G |
Edar |
ectodysplasin-A receptor |
affects expression |
ISO |
diethyl malate affects the expression of EDAR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:28,179,132...28,263,092
Ensembl chr20:28,179,140...28,263,037
|
|
G |
Ednra |
endothelin receptor type A |
affects expression |
ISO |
diethyl malate affects the expression of EDNRA mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of EPAS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
|
|
G |
Epha7 |
Eph receptor A7 |
affects expression |
ISO |
diethyl malate affects the expression of EPHA7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:43,602,744...43,761,198
Ensembl chr 5:43,603,043...43,757,549
|
|
G |
Ephb2 |
Eph receptor B2 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:155,024,478...155,143,539
Ensembl chr 5:155,022,493...155,204,456
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
ISO |
diethyl malate affects the expression of EPHB6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:70,903,253...70,918,514
Ensembl chr 4:70,903,253...70,918,514
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
affects expression |
ISO |
diethyl malate affects the expression of FGF10 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:51,673,480...51,747,533
Ensembl chr 2:51,672,722...51,750,369
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of FGF18 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr10:18,047,109...18,082,290
Ensembl chr10:18,047,109...18,063,391
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FGFR2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:200,590,951...200,696,946
Ensembl chr 1:200,590,953...200,696,928
|
|
G |
Fst |
follistatin |
affects expression |
ISO |
diethyl malate affects the expression of FST mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
|
|
G |
Fzd2 |
frizzled class receptor 2 |
affects expression |
ISO |
diethyl malate affects the expression of FZD2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:90,550,147...90,552,057
Ensembl chr10:90,550,147...90,552,057
|
|
G |
Fzd7 |
frizzled class receptor 7 |
affects expression |
ISO |
diethyl malate affects the expression of FZD7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:66,305,731...66,308,550
Ensembl chr 9:66,305,731...66,308,550
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
ISO |
diethyl malate affects the expression of GCLC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GCLM mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Ggt6 |
gamma-glutamyl transferase 6 |
affects expression |
ISO |
diethyl malate affects the expression of GGT6 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:58,995,253...58,998,431
Ensembl chr10:58,995,556...58,998,033
|
|
G |
Gli2 |
GLI family zinc finger 2 |
affects expression |
ISO |
diethyl malate affects the expression of GLI2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr13:34,829,021...35,049,172
Ensembl chr13:34,829,139...35,048,444
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
affects expression |
ISO |
diethyl malate affects the expression of GNAO1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:11,513,201...11,669,578
Ensembl chr19:11,513,201...11,669,578
|
|
G |
Gng7 |
G protein subunit gamma 7 |
affects expression |
ISO |
diethyl malate affects the expression of GNG7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:11,565,740...11,629,519
Ensembl chr 7:11,582,984...11,628,929
|
|
G |
Gsr |
glutathione-disulfide reductase |
affects expression |
ISO |
diethyl malate affects the expression of GSR mRNA |
CTD |
PMID:24814887 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gss |
glutathione synthetase |
multiple interactions affects expression |
ISO |
S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSS mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of GSTA3 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA3 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 9:27,357,490...27,417,023
Ensembl chr 9:27,402,381...27,417,023
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of GSTA1 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of GSTA1 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1A1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:181,045,694...181,103,321
Ensembl chr 2:181,045,703...181,102,918
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
affects expression |
ISO |
diethyl malate affects the expression of GUCY1B1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:180,976,939...181,026,001
Ensembl chr 2:180,976,939...181,026,024
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
affects expression |
ISO |
diethyl malate affects the expression of HCK mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:148,579,917...148,623,026
Ensembl chr 3:148,579,920...148,623,033
|
|
G |
Hgf |
hepatocyte growth factor |
affects expression |
ISO |
diethyl malate affects the expression of HGF mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Igf1 |
insulin-like growth factor 1 |
affects expression |
ISO |
diethyl malate affects the expression of IGF1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
|
|
G |
Il15 |
interleukin 15 |
affects expression |
ISO |
diethyl malate affects the expression of IL15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr19:23,542,606...23,624,366
Ensembl chr19:23,542,889...23,554,594
|
|
G |
Il18 |
interleukin 18 |
affects expression |
ISO |
diethyl malate affects the expression of IL18 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Irag1 |
inositol 1,4,5-triphosphate receptor associated 1 |
affects expression |
ISO |
diethyl malate affects the expression of IRAG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:175,681,960...175,804,737
Ensembl chr 1:175,681,960...175,796,040
|
|
G |
Irf7 |
interferon regulatory factor 7 |
affects expression |
ISO |
diethyl malate affects the expression of IRF7 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects expression |
ISO |
diethyl malate affects the expression of ISG15 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:173,624,862...173,629,124
Ensembl chr 5:173,624,310...173,626,248
|
|
G |
Itga11 |
integrin subunit alpha 11 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA11 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:67,566,874...67,683,973
Ensembl chr 8:67,615,635...67,683,973
|
|
G |
Itga3 |
integrin subunit alpha 3 |
affects expression |
ISO |
diethyl malate affects the expression of ITGA3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:82,855,841...82,887,755
Ensembl chr10:82,855,613...82,887,497
|
|
G |
Kcnmb4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
affects expression |
ISO |
diethyl malate affects the expression of KCNMB4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:59,461,808...59,514,759
Ensembl chr 7:59,461,799...59,514,939
|
|
G |
Lama1 |
laminin subunit alpha 1 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:115,916,907...116,042,123
Ensembl chr 9:115,916,907...116,042,123
|
|
G |
Lama4 |
laminin subunit alpha 4 |
affects expression |
ISO |
diethyl malate affects the expression of LAMA4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:44,060,715...44,201,966
Ensembl chr20:44,060,731...44,209,614
|
|
G |
LOC100909797 |
RT1 class I histocompatibility antigen, AA alpha chain-like |
affects expression |
ISO |
diethyl malate affects the expression of H2-M3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr20:3,242,236...3,253,995
Ensembl chr20:3,242,470...3,249,189
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK1 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK1 protein] |
CTD |
PMID:24814887 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects phosphorylation multiple interactions |
ISO |
diethyl malate affects the phosphorylation of MAPK3 protein S-ethyl glutathione inhibits the reaction [diethyl malate affects the phosphorylation of MAPK3 protein] |
CTD |
PMID:24814887 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Myl9 |
myosin light chain 9 |
affects expression |
ISO |
diethyl malate affects the expression of MYL9 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:152,857,573...152,863,961
Ensembl chr 3:152,857,592...152,863,960
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
affects expression |
ISO |
diethyl malate affects the expression of ODC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 6:42,852,529...42,859,142
Ensembl chr 6:42,852,683...42,859,927
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of PDGFB mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of PDGFB mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
|
|
G |
Pdgfd |
platelet derived growth factor D |
affects expression |
ISO |
diethyl malate affects the expression of PDGFD mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:4,441,010...4,666,754
Ensembl chr 8:4,440,876...4,669,014
|
|
G |
Pf4 |
platelet factor 4 |
affects expression |
ISO |
diethyl malate affects the expression of PF4 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:18,848,549...18,849,258
Ensembl chr14:18,848,549...18,849,258
|
|
G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
affects expression |
ISO |
diethyl malate affects the expression of PIK3IP1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr14:83,559,397...83,572,481
Ensembl chr14:83,560,541...83,572,473
|
|
G |
Plxnc1 |
plexin C1 |
affects expression |
ISO |
diethyl malate affects the expression of PLXNC1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:35,848,083...36,000,969
Ensembl chr 7:35,850,398...36,000,906
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
affects expression |
ISO |
diethyl malate affects the expression of PRKG1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:248,982,039...250,300,952
|
|
G |
Ptgis |
prostaglandin I2 synthase |
affects expression |
ISO |
diethyl malate affects the expression of PTGIS mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:163,950,746...163,986,129
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
affects expression |
ISO |
diethyl malate affects the expression of RAMP2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr10:89,166,170...89,168,962
Ensembl chr10:89,166,890...89,168,965
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
affects expression |
ISO |
diethyl malate affects the expression of RGS3 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:78,429,017...78,567,281
Ensembl chr 5:78,428,669...78,567,288
|
|
G |
Runx1t1 |
RUNX1 partner transcriptional co-repressor 1 |
affects expression |
ISO |
diethyl malate affects the expression of RUNX1T1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:27,284,921...27,440,802
Ensembl chr 5:27,312,928...27,442,841
|
|
G |
Sema3b |
semaphorin 3B |
affects expression |
ISO |
diethyl malate affects the expression of SEMA3B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 8:116,353,791...116,362,655
Ensembl chr 8:116,354,073...116,361,343
|
|
G |
Sema4g |
semaphorin 4G |
affects expression |
ISO |
diethyl malate affects the expression of SEMA4G mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:264,738,935...264,753,399
Ensembl chr 1:264,741,911...264,753,397
|
|
G |
Sema5a |
semaphorin 5A |
affects expression |
ISO |
diethyl malate affects the expression of SEMA5A mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 2:85,377,318...85,808,970
Ensembl chr 2:85,377,318...85,808,970
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
affects expression |
ISO |
diethyl malate affects the expression of STAT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
affects expression multiple interactions |
ISO |
diethyl malate affects the expression of TGFB2 mRNA S-ethyl glutathione inhibits the reaction [diethyl malate affects the expression of TGFB2 mRNA] |
CTD |
PMID:24814887 |
|
NCBI chr13:105,039,639...105,142,010
Ensembl chr13:105,039,853...105,141,030
|
|
G |
Thbs1 |
thrombospondin 1 |
affects expression |
ISO |
diethyl malate affects the expression of THBS1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Thbs2 |
thrombospondin 2 |
affects expression |
ISO |
diethyl malate affects the expression of THBS2 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:56,653,929...56,683,571
Ensembl chr 1:56,653,938...56,683,731
|
|
G |
Tnc |
tenascin C |
affects expression |
ISO |
diethyl malate affects the expression of TNC mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 5:79,789,686...79,874,555
Ensembl chr 5:79,789,671...79,874,671
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
affects expression |
ISO |
diethyl malate affects the expression of TNFRSF11B mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 7:93,798,580...93,826,586
Ensembl chr 7:93,798,545...93,826,665
|
|
G |
Tnnt1 |
troponin T1, slow skeletal type |
affects expression |
ISO |
diethyl malate affects the expression of TNNT1 mRNA |
CTD |
PMID:24814887 |
|
NCBI chr 1:72,889,270...72,899,629
Ensembl chr 1:72,889,270...72,899,659
|
|
G |
Tslp |
thymic stromal lymphopoietin |
affects expression |
ISO |
diethyl malate affects the expression of TSLP mRNA |
CTD |
PMID:24814887 |
|
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of ABCC2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
diethyl maleate results in increased expression of ABHD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ACACA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:71,519,392...71,719,910
Ensembl chr10:71,536,533...71,719,910
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
EXP |
diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]; resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]] |
CTD |
PMID:17134953 |
|
NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
|
|
G |
Acy3 |
aminoacylase 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ACY3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:219,233,712...219,237,103
Ensembl chr 1:219,233,750...219,237,098
|
|
G |
Adora3 |
adenosine A3 receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ADORA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:208,336,909...208,379,217
Ensembl chr 2:208,373,154...208,376,803
|
|
G |
Afp |
alpha-fetoprotein |
increases expression |
ISO |
diethyl maleate results in increased expression of AFP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:19,141,755...19,159,919
Ensembl chr14:19,141,755...19,159,923
|
|
G |
Ahcyl1 |
adenosylhomocysteinase-like 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of AHCYL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:210,438,884...210,474,350
Ensembl chr 2:210,438,893...210,473,761
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
EXP |
diethyl maleate results in increased expression of AKR1A1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
diethyl maleate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects reduction |
ISO |
diethyl maleate affects the reduction of ALDH1A1 protein |
CTD |
PMID:19843705 |
|
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases reduction increases expression decreases expression |
ISO EXP |
diethyl maleate results in decreased reduction of ALDH2 protein diethyl maleate results in increased expression of ALDH2 protein diethyl maleate results in decreased expression of ALDH2 protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ALDOB protein |
CTD |
PMID:21161181 |
|
NCBI chr 5:64,805,772...64,818,813
Ensembl chr 5:64,805,773...64,818,824
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:138,704,124...138,707,221
Ensembl chr 7:138,704,126...138,707,221
|
|
G |
Angptl2 |
angiopoietin-like 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:12,262,822...12,292,665
Ensembl chr 3:12,262,822...12,292,663
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANKRD46 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:75,279,443...75,300,442
Ensembl chr 7:75,279,446...75,288,365
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
EXP |
diethyl maleate results in increased expression of ANLN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:23,336,455...23,397,122
Ensembl chr 8:23,337,621...23,390,773
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ANXA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:14,371,921...14,426,503
Ensembl chr14:14,364,008...14,426,437
|
|
G |
Ap3m2 |
adaptor related protein complex 3 subunit mu 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of AP3M2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:74,075,842...74,091,230
Ensembl chr16:74,076,812...74,091,139
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of APAF1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
|
|
G |
Aplp1 |
amyloid beta precursor like protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of APLP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:88,897,525...88,908,750
Ensembl chr 1:88,897,532...88,908,750
|
|
G |
Apol9a |
apolipoprotein L 9a |
decreases expression |
EXP |
diethyl maleate results in decreased expression of APOL9A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:118,927,013...118,933,778
Ensembl chr 7:118,927,008...118,933,812
|
|
G |
Arrdc2 |
arrestin domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ARRDC2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:20,352,480...20,356,612
Ensembl chr16:20,352,480...20,356,612
|
|
G |
Arrdc4 |
arrestin domain containing 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ARRDC4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:129,766,097...129,780,076
Ensembl chr 1:129,766,100...129,780,356
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
EXP |
diethyl maleate results in increased expression of ASF1B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:25,077,918...25,092,491
Ensembl chr19:25,077,918...25,092,491
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ASXL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
|
|
G |
Atm |
ATM serine/threonine kinase |
increases expression |
ISO |
diethyl maleate results in increased expression of ATM mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
EXP |
diethyl maleate results in increased expression of ATP5F1B protein |
CTD |
PMID:21161181 |
|
NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
|
|
G |
Aurka |
aurora kinase A |
increases expression decreases expression |
EXP ISO |
diethyl maleate results in increased expression of AURKA mRNA diethyl maleate results in decreased expression of AURKA mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BCL2A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:96,551,424...96,559,527
Ensembl chr 8:96,551,245...96,559,483
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
decreases expression |
ISO |
diethyl maleate results in decreased expression of BCL3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:80,730,758...80,745,273
Ensembl chr 1:80,730,499...80,744,831
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BCL6B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:56,834,363...56,840,058
Ensembl chr10:56,834,364...56,839,437
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BHLHE41 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:180,230,742...180,235,138
Ensembl chr 4:180,232,382...180,234,804
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BHMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:23,236,573...23,256,158
Ensembl chr 2:23,236,575...23,256,158
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA] |
CTD |
PMID:12774022 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
diethyl maleate results in increased expression of BLVRB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
|
|
G |
Bmf |
Bcl2 modifying factor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BMF mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:110,303,515...110,324,125
Ensembl chr 3:110,306,067...110,324,084
|
|
G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of BRIP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:73,507,009...73,632,742
Ensembl chr10:73,507,100...73,629,581
|
|
G |
Btbd2 |
BTB domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of BTBD2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:11,929,859...11,943,559
Ensembl chr 7:11,930,135...11,942,799
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression decreases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of BTG2 mRNA diethyl maleate results in decreased expression of BTG2 mRNA NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] |
CTD |
PMID:22003191 PMID:25270620 |
|
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
C6 |
complement C6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of C6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:54,460,333...54,533,801
Ensembl chr 2:54,466,280...54,533,797
|
|
G |
Casp2 |
caspase 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP2 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 4:71,652,358...71,670,228
Ensembl chr 4:71,652,354...71,670,239
|
|
G |
Casp3 |
caspase 3 |
increases expression increases cleavage |
ISO |
diethyl maleate results in increased expression of CASP3 mRNA diethyl maleate results in increased cleavage of CASP3 protein |
CTD |
PMID:11875189 PMID:21105742 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
diethyl maleate results in increased expression of CASP9 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CAT protein |
CTD |
PMID:21161181 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of CBR1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:33,813,041...33,815,418
Ensembl chr11:33,845,463...33,847,793
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of CBR3 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diethyl maleate results in increased expression of CBR3 mRNA] |
CTD |
PMID:20806931 PMID:25270620 |
|
NCBI chr11:33,909,417...33,917,674
Ensembl chr11:33,909,439...33,917,674
|
|
G |
Ccdc50 |
coiled-coil domain containing 50 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCDC50 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:76,742,179...76,804,695
Ensembl chr11:76,747,865...76,804,510
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNA1 mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CCNA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:123,274,727...123,282,266
Ensembl chr 2:123,275,881...123,282,214
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression increases expression |
ISO EXP |
diethyl maleate results in decreased expression of CCND1 mRNA diethyl maleate results in increased expression of CCND1 mRNA |
CTD |
PMID:11875189 PMID:21161181 PMID:25270620 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CCNE2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:24,434,077...24,446,406
Ensembl chr 5:24,434,872...24,446,406
|
|
G |
Ccnk |
cyclin K |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CCNK mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 6:132,090,235...132,113,560
Ensembl chr 6:132,090,218...132,113,557
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein diethyl maleate results in increased expression of CD80 protein |
CTD |
PMID:31958493 |
|
NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions increases expression |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; bisindolylmaleimide I inhibits the reaction [diethyl maleate results in increased expression of CD86 protein] |
CTD |
PMID:24136171 PMID:31958493 |
|
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
EXP |
diethyl maleate results in increased expression of CDC25A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:44,365,396...44,411,601
Ensembl chr15:44,365,405...44,411,004
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:157,347,876...157,351,889
Ensembl chr 4:157,348,020...157,351,604
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
EXP |
diethyl maleate results in increased expression of CDCA8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:142,911,310...142,933,536
Ensembl chr 5:142,911,305...142,933,526
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CDH11 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:2,391,181...2,551,245
Ensembl chr19:2,393,059...2,551,245
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
diethyl maleate results in increased expression of CDKN1A mRNA; diethyl maleate results in increased expression of CDKN1A protein TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein] |
CTD |
PMID:11875189 PMID:27982581 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cds2 |
CDP-diacylglycerol synthase 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of CDS2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:124,896,657...124,935,221
Ensembl chr 3:124,896,618...124,935,226
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression increases reduction |
EXP ISO |
diethyl maleate results in decreased expression of CES1D protein diethyl maleate results in increased reduction of CES1D protein |
CTD |
PMID:19843705 PMID:21161181 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CFLAR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CIDEC mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:145,377,482...145,390,497
Ensembl chr 4:145,377,431...145,390,497
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CITED2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:12,823,363...12,825,806
Ensembl chr 1:12,823,363...12,825,786
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CITED4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:139,597,731...139,598,622
Ensembl chr 5:139,597,731...139,598,622
|
|
G |
Ckb |
creatine kinase B |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of CKB protein |
CTD |
PMID:19843705 |
|
NCBI chr 6:136,142,956...136,145,838
Ensembl chr 6:136,142,956...136,145,837
|
|
G |
Cmpk2 |
cytidine/uridine monophosphate kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CMPK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:45,683,242...45,694,824
Ensembl chr 6:45,683,234...45,694,822
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
diethyl maleate results in decreased expression of COL1A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
diethyl maleate results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:52,023,295...52,059,221
Ensembl chr 9:52,023,295...52,059,217
|
|
G |
Commd3 |
COMM domain containing 3 |
increases expression |
ISO |
diethyl maleate results in increased expression of COMMD3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:85,356,042...85,359,835
Ensembl chr17:85,356,042...85,359,833
|
|
G |
Comt |
catechol-O-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of COMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
ISO |
diethyl maleate results in decreased expression of CP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CRYM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:189,944,895...189,960,069
Ensembl chr 1:189,944,895...189,960,073
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of CSRP3 protein |
CTD |
PMID:19843705 |
|
NCBI chr 1:104,147,205...104,166,389
Ensembl chr 1:104,147,206...104,166,367
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL12 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CXCL9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
|
|
G |
Cyb5a |
cytochrome b5 type A |
increases expression |
ISO |
diethyl maleate results in increased expression of CYB5A mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:101,687,896...101,692,845
Ensembl chr 1:101,687,855...101,692,846
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
diethyl maleate results in increased expression of DDIT4L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:242,882,219...242,885,088
Ensembl chr 2:242,882,306...242,885,131
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DHX58 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:88,599,722...88,611,562
Ensembl chr10:88,599,680...88,611,105
|
|
G |
Dnmbp |
dynamin binding protein |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DNMBP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:263,625,503...263,718,784
Ensembl chr 1:263,625,501...263,718,745
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of DPYSL2 protein |
CTD |
PMID:19843705 |
|
NCBI chr15:43,475,640...43,581,725
Ensembl chr15:43,477,629...43,542,939
|
|
G |
Dtx3l |
deltex E3 ubiquitin ligase 3L |
decreases expression |
EXP |
diethyl maleate results in decreased expression of DTX3L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:67,758,093...67,767,623 NCBI chr11:67,768,542...67,772,428
Ensembl chr11:67,757,928...67,767,622
|
|
G |
Dus3l |
dihydrouridine synthase 3-like |
decreases expression |
ISO |
diethyl maleate results in decreased expression of DUS3L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:10,289,440...10,294,213
Ensembl chr 9:10,289,446...10,293,980
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of EEF2K mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:190,780,211...190,839,926
Ensembl chr 1:190,780,236...190,842,324
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:1,428,845...1,466,193
Ensembl chr 6:1,428,834...1,466,201
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
increases expression |
ISO |
diethyl maleate results in increased expression of ENTPD5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579
|
|
G |
Eras |
ES cell expressed Ras |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ERAS mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:15,318,215...15,322,601
Ensembl chr X:15,419,028...15,423,414 Ensembl chr X:15,419,028...15,423,414
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
increases expression |
EXP |
diethyl maleate results in increased expression of ERCC6L mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:72,018,373...72,034,140
Ensembl chr X:72,018,373...72,034,099
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of EXO1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr13:93,936,989...93,962,749
Ensembl chr13:93,939,022...93,960,342
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of FABP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FABP7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:40,769,624...40,773,156
Ensembl chr20:40,769,586...40,773,349
|
|
G |
Fam126b |
family with sequence similarity 126, member B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FAM126B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:65,406,136...65,478,399
Ensembl chr 9:65,406,138...65,442,257
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FASN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FBN1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FBP1 protein |
CTD |
PMID:21161181 |
|
NCBI chr17:396,175...417,480
Ensembl chr17:396,180...417,480
|
|
G |
Fgf17 |
fibroblast growth factor 17 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FGF17 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:52,326,758...52,337,360
Ensembl chr15:52,326,778...52,332,097
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FGG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of FGR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:151,172,189...151,199,746
Ensembl chr 5:151,172,206...151,199,745
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of FNDC3B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
diethyl maleate results in increased expression of FOS mRNA |
CTD |
PMID:10915739 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of G6PC mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity |
EXP |
diethyl maleate results in increased activity of G6PD protein |
CTD |
PMID:3099627 |
|
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GAB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:30,794,290...30,903,819
Ensembl chr19:30,794,571...30,902,008
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases reduction |
ISO |
diethyl maleate results in increased reduction of GAPDH protein |
CTD |
PMID:19843705 |
|
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
|
|
G |
Gba2 |
glucosylceramidase beta 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GBA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:59,068,081...59,079,719
Ensembl chr 5:59,068,081...59,079,719
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GBP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity increases expression |
ISO EXP |
diethyl maleate results in increased activity of GCLC protein diethyl maleate results in increased expression of GCLC mRNA; diethyl maleate results in increased expression of GCLC protein |
CTD |
PMID:10915739 PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP ISO |
diethyl maleate results in increased expression of GCLM mRNA; diethyl maleate results in increased expression of GCLM protein |
CTD |
PMID:10978506 PMID:15115889 PMID:21465251 PMID:25270620 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GLUL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GOT2 protein |
CTD |
PMID:21161181 |
|
NCBI chr19:9,587,637...9,613,323
Ensembl chr19:9,587,653...9,613,340
|
|
G |
Gpihbp1 |
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of GPIHBP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:116,632,496...116,635,543
Ensembl chr 7:116,632,506...116,634,293
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GRIA3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:127,561,843...127,829,763
Ensembl chr X:127,562,660...127,829,753
|
|
G |
Gsn |
gelsolin |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of GSN protein |
CTD |
PMID:19843705 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
diethyl maleate results in increased expression of GSR mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gss |
glutathione synthetase |
increases expression |
EXP |
diethyl maleate results in increased expression of GSS mRNA |
CTD |
PMID:10978506 |
|
NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:85,640,081...85,645,621
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTA3 protein |
CTD |
PMID:9794803 |
|
NCBI chr 9:27,357,490...27,417,023
Ensembl chr 9:27,402,381...27,417,023
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTA5 protein |
CTD |
PMID:9794803 |
|
NCBI chr 8:85,553,659...85,564,914
Ensembl chr 8:85,553,734...85,565,179
|
|
G |
Gsta6 |
glutathione S-transferase alpha 6 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTA2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:27,475,273...27,533,939
Ensembl chr 9:27,475,273...27,511,176
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
ISO |
[diethyl maleate results in decreased abundance of Glutathione] which results in decreased expression of GSTK1 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of GSTM1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of GSTO1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTP1 protein |
CTD |
PMID:9794803 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GSTT1 protein |
CTD |
PMID:9794803 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of GTSE1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:126,736,416...126,753,221
Ensembl chr 7:126,736,732...126,753,220
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression |
ISO |
diethyl maleate results in increased expression of H6PD mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:166,994,683...167,030,441
Ensembl chr 5:166,998,881...167,030,441
|
|
G |
Helb |
DNA helicase B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of HELB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:64,860,641...64,888,146
Ensembl chr 7:64,860,666...64,887,448
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HES6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:98,549,698...98,551,438
Ensembl chr 9:98,549,705...98,551,438
|
|
G |
Hjurp |
Holliday junction recognition protein |
increases expression |
EXP |
diethyl maleate results in increased expression of HJURP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:95,347,739...95,362,228
Ensembl chr 9:95,349,086...95,362,014
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of HMOX1 mRNA |
CTD |
PMID:20491607 PMID:25270620 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of HNRNPH1 protein |
CTD |
PMID:19843705 |
|
NCBI chr10:35,872,619...35,879,911
Ensembl chr10:35,870,232...35,879,910
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:50,246,404...50,317,892
Ensembl chr19:50,246,402...50,317,891
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases reduction |
ISO |
diethyl maleate results in decreased reduction of HSPA5 protein |
CTD |
PMID:19843705 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases reduction |
ISO |
diethyl maleate results in increased reduction of HSPA8 protein |
CTD |
PMID:19843705 |
|
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
diethyl maleate results in increased expression of HTATIP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:105,094,272...105,109,459
Ensembl chr 1:105,094,411...105,109,461
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ICAM1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Id3 |
inhibitor of DNA binding 3, HLH protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ID3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
|
|
G |
Id4 |
inhibitor of DNA binding 4, HLH protein |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ID4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:16,692,557...16,695,126
Ensembl chr17:16,692,557...16,695,126
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IFIT3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:252,906,234...252,911,377
Ensembl chr 1:252,906,234...252,911,382
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
decreases expression |
ISO |
diethyl maleate results in decreased expression of IKBKE mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:48,031,325...48,056,394
Ensembl chr13:48,031,410...48,056,394
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
increases expression |
ISO |
diethyl maleate results in increased expression of IKBKG mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:156,254,187...156,280,046
Ensembl chr X:156,257,173...156,270,748
|
|
G |
Il10 |
interleukin 10 |
increases secretion |
ISO |
diethyl maleate results in increased secretion of IL10 protein |
CTD |
PMID:31958493 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
diethyl maleate results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 protein] |
CTD |
PMID:7476933 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein |
CTD |
PMID:31958493 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Inhbb |
inhibin subunit beta B |
decreases expression |
ISO |
diethyl maleate results in decreased expression of INHBB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:35,436,532...35,442,222
Ensembl chr13:35,436,532...35,442,222
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of INMT mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:85,381,907...85,386,203
Ensembl chr 4:85,381,889...85,386,231
|
|
G |
Ints7 |
integrator complex subunit 7 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of INTS7 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:110,257,571...110,310,413
Ensembl chr13:110,257,571...110,310,413
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRF7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
|
|
G |
Irf9 |
interferon regulatory factor 9 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRF9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:34,282,936...34,288,981
Ensembl chr15:34,282,936...34,288,138
|
|
G |
Irgm |
immunity-related GTPase M |
decreases expression |
EXP |
diethyl maleate results in decreased expression of IRGM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:34,213,885...34,221,968
Ensembl chr10:34,213,936...34,221,928
|
|
G |
Itgal |
integrin subunit alpha L |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ITGAL mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:198,744,053...198,781,745
Ensembl chr 1:198,744,050...198,781,750
|
|
G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ITIH3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:6,983,779...7,007,288
Ensembl chr16:6,992,062...7,007,287
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ITIH4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:6,970,367...6,985,538
Ensembl chr16:6,970,342...6,985,579
|
|
G |
Jam3 |
junctional adhesion molecule 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of JAM3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:28,147,110...28,208,466
Ensembl chr 8:28,147,111...28,208,466
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression increases phosphorylation |
ISO |
pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]; TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein] diethyl maleate results in increased expression of JUN mRNA |
CTD |
PMID:10915739 PMID:12774022 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kcne3 |
potassium voltage-gated channel subfamily E regulatory subunit 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of KCNE3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:165,189,934...165,196,949
Ensembl chr 1:165,189,985...165,196,948
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of KEAP1 protein |
CTD |
PMID:27358234 |
|
NCBI chr 8:22,250,518...22,259,868
Ensembl chr 8:22,250,518...22,259,779
|
|
G |
Kifc1 |
kinesin family member C1 |
increases expression |
EXP |
diethyl maleate results in increased expression of KIFC1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:5,509,059...5,526,175
Ensembl chr20:5,509,059...5,526,175
|
|
G |
Klf10 |
Kruppel-like factor 10 |
decreases expression |
EXP ISO |
diethyl maleate results in decreased expression of KLF10 mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr 7:77,156,010...77,162,096
Ensembl chr 7:77,156,006...77,162,148
|
|
G |
Krt75 |
keratin 75 |
increases reduction |
ISO |
diethyl maleate results in increased reduction of KRT75 protein |
CTD |
PMID:19843705 |
|
NCBI chr 7:143,219,012...143,228,237
Ensembl chr 7:143,219,012...143,228,060
|
|
G |
Lama1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LAMA1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:115,916,907...116,042,123
Ensembl chr 9:115,916,907...116,042,123
|
|
G |
Lancl2 |
LanC like 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of LANCL2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:88,524,212...88,565,113
Ensembl chr 4:88,525,695...88,565,292
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LDLR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
G |
Lepr |
leptin receptor |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LEPR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:107,415,334...107,424,672
Ensembl chr10:107,415,326...107,424,710
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
EXP |
diethyl maleate results in increased expression of LMNB1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
|
|
G |
Lmo7 |
LIM domain 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LMO7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:86,242,911...86,458,512
Ensembl chr15:86,243,148...86,457,739
|
|
G |
LOC100363405 |
hypothetical LOC100363405 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of ZFP37 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:77,265,335...77,294,739
Ensembl chr 5:77,266,842...77,294,765
|
|
G |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LRIG3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:69,213,098...69,263,251
Ensembl chr 7:69,213,147...69,263,142
|
|
G |
Lrrn4 |
leucine rich repeat neuronal 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of LRRN4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:125,521,879...125,547,685
Ensembl chr 3:125,523,781...125,533,600
|
|
G |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LRTM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:151,375,568...151,397,485
Ensembl chr 4:151,375,572...151,390,263
|
|
G |
Ltc4s |
leukotriene C4 synthase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LTC4S mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:35,736,486...35,743,088
Ensembl chr10:35,737,664...35,739,625
|
|
G |
Lum |
lumican |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LUM mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:38,820,058...38,826,862
Ensembl chr 7:38,819,771...38,826,862
|
|
G |
Ly6c |
Ly6-C antigen |
decreases expression |
EXP |
diethyl maleate results in decreased expression of LY6C mRNA |
CTD |
PMID:21161181 |
|
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
diethyl maleate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:120,580,743...120,592,095
Ensembl chr 7:120,580,743...120,592,095
|
|
G |
Maoa |
monoamine oxidase A |
increases expression |
ISO |
diethyl maleate results in increased expression of MAOA mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:6,554,698...6,620,722
Ensembl chr X:6,554,698...6,620,722
|
|
G |
Marveld1 |
MARVEL domain containing 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MARVELD1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:261,389,804...261,393,736
Ensembl chr 1:261,389,804...261,393,736
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
EXP |
diethyl maleate results in increased expression of MCM10 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:77,224,218...77,245,486
Ensembl chr17:77,224,112...77,246,478
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of MCM4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:89,511,191...89,524,892
Ensembl chr11:89,511,191...89,524,892
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of ME1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
|
|
G |
Mfap4 |
microfibril associated protein 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MFAP4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:47,765,463...47,768,484
Ensembl chr10:47,765,432...47,768,483
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases activity |
ISO |
diethyl maleate results in decreased activity of MGMT protein |
CTD |
PMID:16950796 |
|
NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
diethyl maleate results in increased expression of MKI67 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mknk2 |
MAPK interacting serine/threonine kinase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MKNK2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:11,908,107...11,919,161
Ensembl chr 7:11,908,107...11,919,156
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
increases expression |
ISO |
diethyl maleate results in increased expression of MMP12 mRNA |
CTD |
PMID:10216232 |
|
NCBI chr 8:5,594,717...5,616,494
Ensembl chr 8:5,606,592...5,616,493
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MMP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
Msn |
moesin |
increases reduction |
ISO |
diethyl maleate results in increased reduction of MSN protein |
CTD |
PMID:19843705 |
|
NCBI chr X:65,226,834...65,294,192
Ensembl chr X:65,226,748...65,295,810
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of MT1A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
diethyl maleate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of MX1 mRNA; diethyl maleate results in decreased expression of MX2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr11:38,035,306...38,066,185
Ensembl chr11:38,035,450...38,059,950
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of MYBL2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:159,421,638...159,450,087
Ensembl chr 3:159,421,671...159,450,086
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of MYCN mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:38,222,554...38,228,419
Ensembl chr 6:38,222,555...38,228,379
|
|
G |
Nat8 |
N-acetyltransferase 8 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NAT8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:117,525,963...117,527,443
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
increases expression |
EXP |
diethyl maleate results in increased expression of NCAPH mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:119,583,798...119,611,148
Ensembl chr 3:119,583,648...119,611,136
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
affects localization increases activity increases expression multiple interactions decreases response to substance |
ISO EXP |
diethyl maleate affects the localization of NFE2L2 protein diethyl maleate results in increased activity of NFE2L2 protein diethyl maleate results in increased expression of NFE2L2 protein diethyl maleate binds to and results in increased activity of NFE2L2 protein; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] NFE2L2 results in decreased susceptibility to diethyl maleate NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] |
CTD |
PMID:12235164 PMID:20806931 PMID:21465251 PMID:22003191 PMID:27358234 PMID:27982581 PMID:30114225 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] |
CTD |
PMID:12774022 |
|
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
Acetylcysteine inhibits the reaction [diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] |
CTD |
PMID:7532384 PMID:9918918 PMID:12774022 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of NQO1 mRNA |
CTD |
PMID:20491607 PMID:25270620 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NR0B2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NR1D1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:86,683,875...86,690,815
Ensembl chr10:86,683,875...86,690,815
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NREP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:26,183,753...26,212,796
Ensembl chr18:26,185,259...26,211,445
|
|
G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of NSMF mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:2,262,173...2,270,996
Ensembl chr 3:2,262,253...2,270,995
|
|
G |
Ntf3 |
neurotrophin 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of NTF3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:158,636,883...158,705,886
Ensembl chr 4:158,636,884...158,705,886
|
|
G |
Nup153 |
nucleoporin 153 |
multiple interactions affects localization |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]; diethyl maleate results in increased phosphorylation of and results in increased O-linked glycosylation of NUP153 protein |
CTD |
PMID:20041180 |
|
NCBI chr17:18,358,712...18,411,368
Ensembl chr17:18,358,712...18,411,368
|
|
G |
Nup88 |
nucleoporin 88 |
multiple interactions affects localization |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] affects the reaction [diethyl maleate affects the localization of NUP88 protein]; diethyl maleate results in increased phosphorylation of and results in increased glycosylation of NUP88 protein |
CTD |
PMID:20041180 |
|
NCBI chr10:57,581,828...57,606,171
Ensembl chr10:57,581,828...57,606,171
|
|
G |
Oaf |
out at first homolog |
decreases expression |
EXP |
diethyl maleate results in decreased expression of OAF mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:47,511,718...47,529,689
Ensembl chr 8:47,511,719...47,529,689
|
|
G |
Oas1i |
2 ' -5 ' oligoadenylate synthetase 1I |
decreases expression |
EXP |
diethyl maleate results in decreased expression of OAS1I mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:41,155,489...41,167,501
Ensembl chr12:41,155,497...41,167,505
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
multiple interactions |
ISO |
[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of OGG1 mRNA |
CTD |
PMID:22564015 |
|
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Orc1 |
origin recognition complex, subunit 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of ORC1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:128,186,651...128,212,901
Ensembl chr 5:128,190,708...128,210,445
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of P2RX7 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:39,353,613...39,396,042
Ensembl chr12:39,353,613...39,396,042
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
diethyl maleate results in increased cleavage of PARP1 protein |
CTD |
PMID:21105742 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PBLD protein |
CTD |
PMID:21161181 |
|
NCBI chr20:27,103,300...27,118,650
Ensembl chr20:27,103,317...27,117,663
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PCNA mRNA |
CTD |
PMID:11875189 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PDLIM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:51,843,562...51,856,785
Ensembl chr15:51,843,564...51,855,325
|
|
G |
Pdrg1 |
p53 and DNA damage regulated 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of PDRG1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:148,487,056...148,493,225
Ensembl chr 3:148,487,059...148,493,225
|
|
G |
Per2 |
period circadian regulator 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PER2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:98,555,154...98,597,362
Ensembl chr 9:98,555,169...98,597,359
|
|
G |
Per3 |
period circadian regulator 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PER3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:168,088,126...168,123,482
Ensembl chr 5:168,086,998...168,123,395
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases activity |
EXP |
diethyl maleate results in increased activity of PGD protein |
CTD |
PMID:3099627 |
|
NCBI chr 5:165,966,128...165,982,327
|
|
G |
Pgrmc1 |
progesterone receptor membrane component 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of PGRMC1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:123,205,869...123,213,880
Ensembl chr X:123,205,869...123,213,882
|
|
G |
Pir |
pirin |
increases expression |
ISO |
diethyl maleate results in increased expression of PIR mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:31,852,322...31,968,152
Ensembl chr X:31,852,323...31,968,152
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PKLR mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:188,449,158...188,458,034
Ensembl chr 2:188,449,210...188,459,592
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression decreases expression |
EXP ISO |
diethyl maleate results in increased expression of PLAT mRNA diethyl maleate results in decreased expression of PLAT mRNA |
CTD |
PMID:21161181 PMID:25270620 |
|
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Plek |
pleckstrin |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PLEK mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:100,151,518...100,184,192
Ensembl chr14:100,151,210...100,217,913
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions decreases activity |
EXP |
diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]; resveratrol inhibits the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol inhibits the reaction [diethyl maleate results in decreased activity of PPARA protein]; resveratrol promotes the reaction [diethyl maleate inhibits the reaction [PPARA protein binds to ACOX1 promoter]]; resveratrol promotes the reaction [diethyl maleate results in decreased activity of PPARA protein] |
CTD |
PMID:17134953 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Ppargc1b |
PPARG coactivator 1 beta |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PPARGC1B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr18:56,626,725...56,650,524
Ensembl chr18:56,626,712...56,728,968
|
|
G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PPP1R3B mRNA |
CTD |
PMID:21161181 |
|
NCBI chr16:60,415,192...60,427,498
Ensembl chr16:60,415,229...60,427,474
|
|
G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PPP1R3C mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:255,371,830...255,376,833
Ensembl chr 1:255,371,810...255,376,833
|
|
G |
Prdm14 |
PR/SET domain 14 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PRDM14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:5,710,076...5,730,560
Ensembl chr 5:5,710,392...5,730,560
|
|
G |
Prdx1 |
peroxiredoxin 1 |
increases expression |
EXP ISO |
diethyl maleate results in increased expression of PRDX1 mRNA |
CTD |
PMID:9506838 |
|
NCBI chr 5:135,536,413...135,551,986
Ensembl chr 5:135,536,413...135,551,990
|
|
G |
Prkab1 |
protein kinase AMP-activated non-catalytic subunit beta 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PRKAB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:46,316,298...46,326,789
Ensembl chr12:46,316,236...46,326,790
|
|
G |
Prkcb |
protein kinase C, beta |
affects expression |
ISO |
diethyl maleate affects the expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
EXP |
Cycloheximide inhibits the reaction [diethyl maleate results in increased expression of PRKCD protein]; diethyl maleate results in increased expression of and results in increased activity of PRKCD protein |
CTD |
PMID:11118818 |
|
NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
EXP |
Cycloheximide inhibits the reaction [diethyl maleate results in increased expression of PRKCE protein]; diethyl maleate results in increased expression of and results in increased activity of PRKCE protein |
CTD |
PMID:11118818 |
|
NCBI chr 6:9,483,400...9,973,396
Ensembl chr 6:9,790,422...9,973,396
|
|
G |
Prss8 |
serine protease 8 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of PRSS8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:199,372,519...199,377,035
Ensembl chr 1:199,372,519...199,377,035
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of PTGR1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:76,110,746...76,129,361
Ensembl chr 5:76,110,738...76,129,441
|
|
G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
increases expression |
ISO |
diethyl maleate results in increased expression of PTPN14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:108,689,916...108,841,593
Ensembl chr13:108,696,336...108,841,511
|
|
G |
Pus1 |
pseudouridine synthase 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of PUS1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:51,936,721...51,945,930
Ensembl chr12:51,937,175...51,945,928
|
|
G |
Rab27a |
RAB27A, member RAS oncogene family |
decreases expression |
EXP |
diethyl maleate results in decreased expression of RAB27A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:79,722,334...79,776,228
Ensembl chr 8:79,722,334...79,776,221
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [[carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] which results in increased glutathionylation of RELA protein]; diethyl maleate inhibits the reaction [carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] |
CTD |
PMID:20116392 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rnf114 |
ring finger protein 114 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of RNF114 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:164,248,736...164,260,499
Ensembl chr 3:164,248,731...164,260,497
|
|
G |
Rnf14 |
ring finger protein 14 |
increases expression |
ISO |
diethyl maleate results in increased expression of RNF14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:31,443,424...31,468,641
Ensembl chr18:31,444,472...31,468,640
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
increases expression |
EXP |
diethyl maleate results in increased expression of RRM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of RSAD2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 6:45,655,947...45,669,083
Ensembl chr 6:45,655,954...45,669,148
|
|
G |
RT1-S3 |
RT1 class Ib, locus S3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of RT1-S3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:3,176,124...3,180,825
Ensembl chr20:3,176,107...3,179,818
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of S100A9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:190,097,436...190,100,209
Ensembl chr 2:190,097,554...190,100,276
|
|
G |
Sash3 |
SAM and SH3 domain containing 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SASH3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr X:134,979,637...134,994,351
Ensembl chr X:134,979,646...134,994,349
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SCD1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
|
|
G |
Sds |
serine dehydratase |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SDS mRNA |
CTD |
PMID:21161181 |
|
NCBI chr12:41,620,429...41,627,741
Ensembl chr12:41,620,393...41,627,741
|
|
G |
Serpind1 |
serpin family D member 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SERPIND1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:87,913,814...87,924,880
Ensembl chr11:87,913,806...87,924,816
|
|
G |
Sez6 |
seizure related 6 homolog |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SEZ6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:64,865,802...64,915,461
Ensembl chr10:64,865,805...64,915,148
|
|
G |
Sfxn1 |
sideroflexin 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SFXN1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:11,046,588...11,082,219
Ensembl chr17:11,045,761...11,082,047
|
|
G |
Six4 |
SIX homeobox 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of SIX4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:95,984,868...95,999,709
Ensembl chr 6:95,984,868...95,998,529
|
|
G |
Slc16a6 |
solute carrier family 16, member 6 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC16A6 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:97,733,701...97,758,723
Ensembl chr10:97,735,548...97,756,521
|
|
G |
Slc1a4 |
solute carrier family 1 member 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of SLC1A4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr14:104,582,884...104,612,417
Ensembl chr14:104,581,190...104,612,597
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC2A2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:114,413,427...114,445,418
Ensembl chr 2:114,413,410...114,445,395
|
|
G |
Slc2a5 |
solute carrier family 2 member 5 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC2A5 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:167,142,182...167,174,203
Ensembl chr 5:167,141,875...167,174,310
|
|
G |
Slc39a14 |
solute carrier family 39 member 14 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SLC39A14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:51,982,872...52,029,841
Ensembl chr15:51,982,982...52,029,816
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC40A1 mRNA] |
CTD |
PMID:21303654 |
|
NCBI chr 9:52,819,451...52,830,461
Ensembl chr 9:52,894,365...52,912,293
|
|
G |
Slc44a4 |
solute carrier family 44, member 4 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC44A4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:4,593,389...4,609,641
Ensembl chr20:4,593,389...4,609,631
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions increases expression |
ISO |
NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] |
CTD |
PMID:12235164 |
|
NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
|
|
G |
Slc9a3r1 |
SLC9A3 regulator 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLC9A3R1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:103,713,045...103,730,145
Ensembl chr10:103,713,045...103,730,145
|
|
G |
Slco2a1 |
solute carrier organic anion transporter family, member 2a1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLCO2A1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:111,495,443...111,577,320
Ensembl chr 8:111,495,331...111,577,833
|
|
G |
Slfn3 |
schlafen family member 3 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SLFN3 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:70,438,012...70,477,259
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
increases expression |
EXP |
diethyl maleate results in increased expression of SMC4 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:165,600,934...165,629,415
Ensembl chr 2:165,601,007...165,629,415
|
|
G |
Smtn |
smoothelin |
increases expression |
EXP |
diethyl maleate results in increased expression of SMTN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr14:83,755,141...83,776,871
Ensembl chr14:83,755,142...83,776,863
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SOCS3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [IL1A protein results in increased expression of SOD2 protein]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 protein] |
CTD |
PMID:7476933 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sorl1 |
sortilin related receptor 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SORL1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:46,228,077...46,287,171
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
increases expression |
EXP |
diethyl maleate results in increased expression of SOX9 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
|
|
G |
Sp5 |
Sp5 transcription factor |
decreases expression |
ISO |
diethyl maleate results in decreased expression of SP5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:56,766,475...56,769,277
Ensembl chr 3:56,766,475...56,769,277
|
|
G |
Spc25 |
SPC25 component of NDC80 kinetochore complex |
increases expression |
EXP |
diethyl maleate results in increased expression of SPC25 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:55,438,534...55,451,961
Ensembl chr 3:55,438,536...55,451,798
|
|
G |
Spta1 |
spectrin, alpha, erythrocytic 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of SPTA1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:92,264,231...92,340,091
Ensembl chr13:92,264,231...92,340,083
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases cleavage |
ISO |
diethyl maleate results in increased cleavage of SPTAN1 protein |
CTD |
PMID:21105742 |
|
NCBI chr 3:8,534,437...8,599,259
Ensembl chr 3:8,534,440...8,599,260
|
|
G |
Sptbn4 |
spectrin, beta, non-erythrocytic 4 |
increases expression |
ISO |
diethyl maleate results in increased expression of SPTBN4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:84,168,494...84,254,679
Ensembl chr 1:84,168,495...84,254,645
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SREBF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions increases expression |
ISO |
[Acetylcysteine affects the abundance of Reactive Oxygen Species] inhibits the reaction [diethyl maleate results in increased expression of SRXN1 mRNA]; NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 mRNA] NFE2L2 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein]; TP53 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] diethyl maleate results in increased expression of SRXN1 mRNA; diethyl maleate results in increased expression of SRXN1 protein |
CTD |
PMID:22003191 PMID:25270620 PMID:27358234 PMID:27982581 |
|
NCBI chr 3:147,608,850...147,614,410
Ensembl chr 3:147,609,095...147,632,801
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of STAT1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Steap4 |
STEAP4 metalloreductase |
decreases expression |
ISO |
diethyl maleate results in decreased expression of STEAP4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:23,112,682...23,135,354
Ensembl chr 4:23,090,029...23,135,354
|
|
G |
Sulf2 |
sulfatase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SULF2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:162,791,349...162,872,984
Ensembl chr 3:162,791,355...162,872,831
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of SULT1A1 protein |
CTD |
PMID:21161181 |
|
NCBI chr 1:198,100,586...198,104,106
Ensembl chr 1:198,100,586...198,104,109
|
|
G |
Tagln |
transgelin |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TAGLN mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
|
|
G |
Tbcel |
tubulin folding cofactor E-like |
increases expression |
ISO |
diethyl maleate results in increased expression of TBCEL mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:46,691,488...46,750,816
Ensembl chr 8:46,694,561...46,750,898
|
|
G |
Tent5a |
terminal nucleotidyltransferase 5A |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TENT5A mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:92,935,474...92,942,267
Ensembl chr 8:92,937,739...92,942,076
|
|
G |
Tesmin |
testis expressed metallothionein like protein |
affects localization |
ISO |
diethyl maleate affects the localization of TESMIN protein |
CTD |
PMID:12606435 |
|
NCBI chr 1:218,632,764...218,651,054
Ensembl chr 1:218,632,764...218,651,053
|
|
G |
Tf |
transferrin |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TF protein |
CTD |
PMID:21161181 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tfeb |
transcription factor EB |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TFEB mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:15,208,141...15,264,101
Ensembl chr 9:15,207,822...15,214,596
|
|
G |
Tgm2 |
transglutaminase 2 |
increases expression |
EXP |
diethyl maleate results in increased expression of TGM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of THBS1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
EXP |
diethyl maleate results in decreased expression of THRSP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:162,381,251...162,385,575
Ensembl chr 1:162,381,253...162,385,575
|
|
G |
Tm4sf1 |
transmembrane 4 L six family member 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of TM4SF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:147,382,866...147,392,062
Ensembl chr 2:147,382,866...147,392,062
|
|
G |
Tmem209 |
transmembrane protein 209 |
increases expression |
ISO |
diethyl maleate results in increased expression of TMEM209 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:57,796,337...57,823,283
Ensembl chr 4:57,796,338...57,823,295
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
[diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD80 protein; [diethyl maleate co-treated with IL4 protein co-treated with TNF protein co-treated with Ionomycin] results in increased expression of CD86 protein; diethyl maleate inhibits the reaction [[carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]] which results in increased glutathionylation of RELA protein]; diethyl maleate inhibits the reaction [carnosol inhibits the reaction [TNF protein affects the localization of RELA protein]]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of SOD2 protein] diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of diethyl maleate] diethyl maleate inhibits the reaction [TNF protein results in increased expression of BIRC3 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]; diethyl maleate inhibits the reaction [TNF protein results in increased expression of NOS2 protein]; pyrazolanthrone inhibits the reaction [TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein]]; TNF protein promotes the reaction [diethyl maleate results in increased phosphorylation of JUN protein] |
CTD |
PMID:7476933 PMID:7532384 PMID:12774022 PMID:20116392 PMID:31958493 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf14 |
TNF receptor superfamily member 14 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TNFRSF14 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:172,328,259...172,337,221
Ensembl chr 5:172,328,262...172,335,892
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
TRP53 protein affects the reaction [diethyl maleate results in increased expression of BTG2 mRNA] TP53 protein affects the reaction [diethyl maleate results in increased expression of CDKN1A protein]; TP53 protein affects the reaction [diethyl maleate results in increased expression of SRXN1 protein] |
CTD |
PMID:22003191 PMID:27982581 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Tpm2 |
tropomyosin 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TPM2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 5:59,016,616...59,025,971
Ensembl chr 5:59,016,622...59,025,631
|
|
G |
Trap1 |
TNF receptor-associated protein 1 |
multiple interactions decreases response to substance |
ISO |
diethyl maleate inhibits the reaction [Cisplatin results in decreased expression of TRAP1 protein] TRAP1 protein results in decreased susceptibility to diethyl maleate |
CTD |
PMID:17853063 |
|
NCBI chr10:11,724,032...11,757,682
Ensembl chr10:11,724,032...11,757,681
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TRDMT1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:80,824,652...80,859,585
Ensembl chr17:80,826,846...80,860,195
|
|
G |
Trim6 |
tripartite motif containing 6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TRIM6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:169,410,084...169,423,305
Ensembl chr 1:169,410,115...169,423,283
|
|
G |
Trip13 |
thyroid hormone receptor interactor 13 |
increases expression |
EXP |
diethyl maleate results in increased expression of TRIP13 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 1:31,967,980...32,012,923
Ensembl chr 1:31,967,978...32,012,919
|
|
G |
Tsc22d1 |
TSC22 domain family, member 1 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TSC22D1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr15:58,554,358...58,658,156
Ensembl chr15:58,554,374...58,658,153
|
|
G |
Tspan8 |
tetraspanin 8 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of TSPAN8 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 7:58,814,805...58,847,564
Ensembl chr 7:58,814,805...58,847,563
|
|
G |
Tstd1 |
thiosulfate sulfurtransferase like domain containing 1 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of TSTD1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:89,805,652...89,807,355
Ensembl chr13:89,805,962...89,807,243
|
|
G |
Txn1 |
thioredoxin 1 |
decreases activity |
ISO |
diethyl maleate results in decreased activity of TXN protein |
CTD |
PMID:15388247 |
|
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression |
EXP |
diethyl maleate results in increased expression of TXNIP mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 2:198,683,168...198,686,971
Ensembl chr 2:198,683,159...198,686,974
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
diethyl maleate results in increased expression of TXNRD1 mRNA |
CTD |
PMID:15521073 |
|
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
|
|
G |
Ubd |
ubiquitin D |
decreases expression |
EXP |
diethyl maleate results in decreased expression of UBD mRNA |
CTD |
PMID:21161181 |
|
NCBI chr20:1,876,175...1,878,126
Ensembl chr20:1,876,173...1,897,814
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
increases expression |
EXP |
diethyl maleate results in increased expression of UHRF1 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 9:10,738,211...10,758,403
Ensembl chr 9:10,738,222...10,757,954
|
|
G |
Usp18 |
ubiquitin specific peptidase 18 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of USP18 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 4:153,812,312...153,834,374
Ensembl chr 4:153,805,993...153,834,430
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of USP2 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:48,403,985...48,432,525
Ensembl chr 8:48,406,260...48,430,885
|
|
G |
Wdr31 |
WD repeat domain 31 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of WDR31 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:78,305,526...78,324,318
Ensembl chr 5:78,305,526...78,324,278
|
|
G |
Wdr6 |
WD repeat domain 6 |
decreases expression |
EXP |
diethyl maleate results in decreased expression of WDR6 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr 8:117,358,345...117,364,761
Ensembl chr 8:117,358,787...117,366,096
|
|
G |
Ypel5 |
yippee-like 5 |
increases expression |
ISO |
diethyl maleate results in increased expression of YPEL5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:24,069,351...24,084,758
Ensembl chr 6:24,064,738...24,084,757
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression |
ISO |
diethyl maleate results in increased expression of ZFP36 protein |
CTD |
PMID:21969073 |
|
NCBI chr 1:85,380,088...85,382,565
Ensembl chr 1:85,380,088...85,382,569
|
|
G |
Zfp367 |
zinc finger protein 367 |
increases expression |
EXP |
diethyl maleate results in increased expression of ZNF367 mRNA |
CTD |
PMID:21161181 |
|
NCBI chr17:1,652,892...1,672,021
Ensembl chr17:1,652,895...1,672,021
|
|
G |
Znrd2 |
zinc ribbon domain containing 2 |
decreases expression |
ISO |
diethyl maleate results in decreased expression of ZNRD2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:221,087,803...221,089,586
Ensembl chr 1:221,087,803...221,089,586
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Dimethyl Fumarate inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30703375 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr 5:33,843,591...33,892,446
Ensembl chr 5:33,843,519...33,892,462
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
affects localization |
ISO |
Dimethyl Fumarate affects the localization of BACH1 protein |
CTD |
PMID:27277809 |
|
NCBI chr11:27,364,913...27,398,713
Ensembl chr11:27,364,916...27,398,842
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]]; Dimethyl Fumarate inhibits the reaction [IKBKB protein results in increased expression of CCL2 mRNA]; Dimethyl Fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to CCL2 promoter]]; Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CCL2 mRNA] Dimethyl Fumarate results in decreased expression of CCL2 mRNA |
CTD |
PMID:26683377 PMID:27277809 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of ATP6V0D2 mRNA]; Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [[sodium arsenite co-treated with CSF1R protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] |
CTD |
PMID:30742845 |
|
NCBI chr 2:196,655,469...196,666,447
Ensembl chr 2:196,655,469...196,666,446
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression multiple interactions |
ISO |
Dimethyl Fumarate results in increased expression of FTH1 mRNA; Dimethyl Fumarate results in increased expression of FTH1 protein NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTH1 mRNA] |
CTD |
PMID:28289076 |
|
NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression multiple interactions |
ISO |
Dimethyl Fumarate results in increased expression of FTL mRNA; Dimethyl Fumarate results in increased expression of FTL protein NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL mRNA]; NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of FTL protein] |
CTD |
PMID:28289076 |
|
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
ISO EXP |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLC mRNA] Dimethyl Fumarate results in increased expression of GCLC protein |
CTD |
PMID:27277809 PMID:30248482 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions increases expression |
ISO EXP |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLM mRNA] Dimethyl Fumarate results in increased expression of GCLM protein |
CTD |
PMID:27277809 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases metabolic processing |
ISO |
Dimethyl Fumarate results in increased metabolism of GPX4 protein |
CTD |
PMID:29917289 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression multiple interactions |
EXP ISO |
Dimethyl Fumarate results in increased expression of GSR protein NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GSR mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
Dimethyl Fumarate results in increased expression of HMOX1 mRNA; Dimethyl Fumarate results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein]; HMOX1 protein inhibits the reaction [Dimethyl Fumarate inhibits the reaction [Lipopolysaccharides results in increased abundance of Dinoprostone]]; NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein] [Dimethyl Fumarate results in decreased abundance of Glutathione] which results in increased expression of HMOX1 protein; [Dimethyl Fumarate results in increased expression of HMOX1 protein] which results in decreased susceptibility to PDGFB protein; Glutathione inhibits the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [Dimethyl Fumarate results in increased expression of HMOX1 protein] |
CTD |
PMID:20961405 PMID:23942037 PMID:26683377 PMID:27277809 PMID:28790194 PMID:29950142 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; Dimethyl Fumarate inhibits the reaction [TNF protein promotes the reaction [RELA protein binds to ICAM1 promoter]]; Dimethyl Fumarate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] Dimethyl Fumarate results in decreased expression of ICAM1 mRNA |
CTD |
PMID:26683377 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [nickel sulfate results in increased secretion of IFNG protein] Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased abundance of Dinoprostone]; Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased abundance of Nitrites]; tin protoporphyrin IX inhibits the reaction [Dimethyl Fumarate inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] |
CTD |
PMID:15663561 PMID:23942037 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
Dimethyl Fumarate inhibits the reaction [IKBKB protein results in increased expression of CCL2 mRNA]; Dimethyl Fumarate inhibits the reaction [IKBKB protein results in increased expression of TNF mRNA] |
CTD |
PMID:26683377 |
|
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Dimethyl Fumarate results in decreased expression of IL6R protein |
CTD |
PMID:28134847 |
|
NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of LAMP2 protein alternative form] |
CTD |
PMID:29950142 |
|
NCBI chr X:124,722,628...124,766,079
Ensembl chr X:124,722,628...124,766,044
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
increases expression multiple interactions |
ISO |
Dimethyl Fumarate results in increased expression of COX3 mRNA NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of COX3 mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of CYTB mRNA] |
CTD |
PMID:27277809 |
|
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [Dimethyl Fumarate results in | |